HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHIC METHOD FOR THE DETERMINATION OF TOREMIFENE AND ITS MAJOR HUMAN METABOLITES

被引：21

作者：

WEBSTER, LK ^{[1
]}

CRINIS, NA ^{[1
]}

STOKES, KH ^{[1
]}

BISHOP, JF ^{[1
]}

机构：

[1] PETER MACCALLUM CANC INST,DEPT PATHOL,MELBOURNE,VIC 3000,AUSTRALIA

来源：

JOURNAL OF CHROMATOGRAPHY-BIOMEDICAL APPLICATIONS | 1991年 / 565卷 / 1-2期

关键词：

D O I：

10.1016/0378-4347(91)80414-8

中图分类号：

O65 [分析化学];

学科分类号：

070302 ; 081704 ;

摘要：

A high-performance liquid chromatographic method has been developed for the measurement of toremifene and its major human metabolites in plasma and urine. We have simplified other published methods, such that our assay uses protein precipitation in place of organic extraction, and ultraviolet detection instead of photochemical activation followed by fluorescence detection. In a stability study toremifene and metabolites remained unchanged for up to seven weeks at - 70-degrees-C. This simple and specific assay allowed toremifene and three metabolites to be quantitated for pharmacokinetic analyses in a high-dose Phase I trial.

引用

页码：482 / 487

页数：6

共 8 条

[1] PHARMACOKINETICS OF TOREMIFENE
ANTTILA, M
VALAVAARA, R
KIVINEN, S
MAENPAA, J
[J]. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY, 1990, 36 (03) : 249 - 252
[2] TOREMIFENE - PHARMACOLOGIC AND PHARMACOKINETIC BASIS OF REVERSING MULTIDRUG RESISTANCE
DEGREGORIO, MW
FORD, JM
BENZ, CC
WIEBE, VJ
[J]. JOURNAL OF CLINICAL ONCOLOGY, 1989, 7 (09) : 1359 - 1364
[3] HOLLERAN WM, 1987, ANAL LETT, V20, P871
[4] HORVATH G, 1990, ANTICANCER RES, V10, P323
[5] A NEW TRIPHENYLETHYLENE COMPOUND, FC-1157A .2. ANTITUMOR EFFECTS
KANGAS, L
NIEMINEN, AL
BLANCO, G
GRONROOS, M
KALLIO, S
KARJALAINEN, A
PERILA, M
SODERVALL, M
TOIVOLA, R
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1986, 17 (02) : 109 - 113
[6] ANTITUMOR ACTIONS OF TOREMIFENE IN THE 7,12-DIMETHYLBENZANTHRACENE (DMBA)-INDUCED RAT MAMMARY-TUMOR MODEL
ROBINSON, SP
MAUEL, DA
JORDAN, VC
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (12): : 1817 - 1821
[7] TOREMIFENE, A NEW ANTIESTROGENIC COMPOUND, FOR TREATMENT OF ADVANCED BREAST-CANCER - PHASE-II STUDY
VALAVAARA, R
PYRHONEN, S
HEIKKINEN, M
RISSANEN, P
BLANCO, G
THOLIX, E
NORDMAN, E
TASKINEN, P
HOLSTI, L
HAJBA, A
[J]. EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1988, 24 (04): : 785 - 790
[8] PHARMACOKINETICS OF TOREMIFENE AND ITS METABOLITES IN PATIENTS WITH ADVANCED BREAST-CANCER
WIEBE, VJ
BENZ, CC
SHEMANO, I
CADMAN, TB
DEGREGORIO, MW
[J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1990, 25 (04) : 247 - 251

← 1 →